Cargando...
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009
BACKGROUND: New emerging infections have no known treatment. Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions and contributes to overall outbreak control. However, it is difficult to launch clinical trials in the unpredictable environmen...
Guardado en:
| Publicado en: | BMC Med |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7441224/ https://ncbi.nlm.nih.gov/pubmed/32825816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-020-01732-5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|